Acceptance and Commitment Therapy for the Improvement of Cancer Distress in Patients With Incurable Cancers, ACT-C Trial

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMayo Clinic

About this trial

This clinical trial studies whether Acceptance and Commitment Therapy can be used to help improve cancer distress for patients with hepatobiliary or breast cancers for which no treatment is currently available (incurable). Patients with hepatobiliary cancer (HBC) and breast cancer often experience high levels of distress and reductions in quality of life. Acceptance and Commitment Therapy for incurable cancers (ACT-C) is a behavioral intervention tailored to patients with incurable HBC and breast cancer. It helps patients cope with difficult thoughts and emotions while staying connected to what matters most in life, which may be an effective way to improve cancer distress.

Eligibility criteria

Qualifiers

Incurable HBC and breast cancer diagnosis

Age >= 18 years

Able to provide written informed consent

Verbally endorse cancer distress

Disqualifiers

Other psychological therapy that started =< 2 months prior to prospective enrollment

Inability to actively participate in and learn from group therapy (e.g., active/uncontrolled psychotic symptoms, neurological condition, personality pathology) as determined by clinical judgement in Behavioral Medicine Program (BMP) consultation. Individual therapy or alternative group therapy will be offered to patients ineligible per this criterion

Cancer remission

Trial design

Treatments tested in this trial

  • Acceptance and Commitment Therapy
  • Questionnaire Administration
  • Telemedicine

Treatment groups

60 Participants
are divided into 1 treatment group

Sponsors and collaborators